Prognostic value of pretreatment platelet counts in lung cancer: a systematic review and meta-analysis
Preprint
- 13 April 2020
- preprint
- review article
- Published by Research Square Platform LLC
Abstract
Background : The prognostic value of elevated pretreatment platelet counts remains controversial in lung cancer patients. We performed the present meta-analysis to determine its precise role in these patients. Methods: We employed a multiple search strategy in the PubMed, EMBASE and Cochrane Library databases to identify eligible studies. Disease-free survival (DFS)/progression-free survival (PFS)/time to progression (TTP) and overall survival (OS) were used as outcomes with hazard ratios (HRs) and 95% confidence intervals (CIs). Heterogeneity among the studies and publication bias were also evaluated. Results : A total of 40 studies including 16696 lung cancer patients were eligible for the analysis. Overall, the pooled analysis showed that compared with normal platelet counts, elevated pretreatment platelet counts were associated with poorer OS (HR= 1.54, 95% CI: 1.37-1.72, P<0.001) and poorer DFS/PFS/TTP (HR=1.62, 95% CI: 1.33-1.98, P<0.001) in patients with lung cancer. In subgroup analyses, elevated pretreatment platelet counts were also associated with poorer OS and DFS/PFS/TTP in most subgroups. There was no evidence of publication bias. Conclusions : This meta-analysis revealed that elevated pretreatment platelet counts were an independent predictor of OS and DFS/PFS/TTP in lung cancer patients. Large-scale prospective studies and a validation study are warranted.Keywords
Other Versions
- Published version: Version BMC Pulmonary Medicine, 20, preprints
This publication has 54 references indexed in Scilit:
- Platelet count predicts prognosis in operable non-small cell lung cancerExperimental and Therapeutic Medicine, 2013
- Thrombocytosis and immunohistochemical expression of connexin 43 at diagnosis predict survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapyCancer Chemotherapy and Pharmacology, 2013
- Paraneoplastic Thrombocytosis in Ovarian CancerThe New England Journal of Medicine, 2012
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes MetastasisCancer Cell, 2011
- Performance of statistical methods for meta-analysis when true study effects are non-normally distributed: A simulation studyStatistical Methods in Medical Research, 2010
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Prognostic impact of thrombocytosis in resectable non-small cell lung cancerInteractive CardioVascular and Thoracic Surgery, 2008
- A prognostic model for advanced stage nonsmall cell lung cancerCancer, 2006
- Prognostic Value of Thrombocytosis in Renal Cell CarcinomaJournal of Urology, 2006
- Prognostic significance of thrombocytosis in patients with primary lung cancerEuropean Respiratory Journal, 1996